Formation of dysfunctional high-density lipoprotein by myeloperoxidase

Trends in Cardiovascular Medicine

Volumn 15, Issue 6, 2005, Pages 212-219

  Nicholls, Stephen J ^a   Zheng, Lemin ^a   Hazen, Stanley L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; MYELOPEROXIDASE; PROTECTIVE AGENT;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHLORINATION; CHOLESTEROL TRANSPORT; INFLAMMATION; NITRATION; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CORONARY ARTERIOSCLEROSIS; HUMANS; LIPOPROTEINS, HDL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE;

EID: 25144473410     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2005.06.004     Document Type: Review

References (58)

1. CJ Albert, JR Crowley, and FF Hsu Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal J Biol Chem 276 2001 23733 23741
2. BJ Ansell, M Navab, and S Hama Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 108 2003 2751 2756
3. DT Ashby, JR Gamble, and MA Vadas Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression Atherosclerosis 154 2001 113 121
4. AT Askari, ML Brennan, and X Zhou Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction J Exp Med 197 2003 615 624
5. FW Asselbergs, JW Tervaert, and RA Tio Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 350 2004 516 518
6. JJ Badimon, L Badimon, and A Galvez High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits Lab Invest 60 1989 455 461
7. S Baldus, C Heeschen, and T Meinertz Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 2003 1440 1445
8. S Baldus, T Heitzer, and JP Eiserich Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion Free Radic Biol Med 37 2004 902 911
9. PJ Barter, S Nicholls, and KA Rye Antiinflammatory properties of HDL Circ Res 95 2004 764 772
10. C Bergt, S Pennathur, and X Fu The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc Natl Acad Sci USA 101 2004 13032 13037
11. JK Bielicki, and MN Oda Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I Biochemistry 41 2002 2089 2096
12. RJ Bisoendial, GK Hovingh, and JHM Levels Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein Circulation 107 2003 2944 2948
13. VW Bowry, KK Stanley, and R Stocker High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc Natl Acad Sci USA 89 1992 10316 10320
14. ML Brennan, MM Anderson, and DM Shih Increased atherosclerosis in myeloperoxidase-deficient mice J Clin Invest 107 2001 419 430
15. ML Brennan, W Wu, and X Fu A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species J Biol Chem 277 2002 17415 17427
16. ML Brennan, MS Penn, and F Van Lente Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604
17. GM Chisholm, and D Steinberg The oxidative modification hypothesis of atherogenesis: an overview Free Radic Biol Med 28 2000 1815 1826
18. JP Eiserich, S Baldus, and ML Brennan Myeloperoxidase, a leukocyte-derived vascular NO oxidase Science 296 2002 2391 2394
19. CJ Fielding, and PE Fielding Molecular physiology of reverse cholesterol transport J Lipid Res 36 1995 211 228
20. CK Glass, and JL Witztum Atherosclerosis: the road ahead Cell 104 2001 503 516
21. T Gordon, WP Castelli, and MC Hjortland High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study Am J Med 62 1977 707 714
22. DJ Gordon, JL Probstfield, and RJ Garrison High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies Circulation 79 1989 8 15
23. MS Gowri, DR Van der Westhuyzen, and SR Bridges Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL Arterioscler Thromb Vasc Biol 19 1999 2226 2233
24. SM Grundy, JI Cleeman, and CN Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
25. D Harrison, KK Griendling, and U Landmesser Role of oxidative stress in atherosclerosis Am J Cardiol 91 2003 7A 11A
26. SL Hazen, and JW Heinecke 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Invest 99 1997 2075 2081
27. H Ischiropoulos, and JS Beckman Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111 2003 163 169
28. PO Kwiterovich Jr The antiatherogenic role of high-density lipoprotein cholesterol Am J Cardiol 82 1998 13Q 21Q
29. J Loscalzo Nitric oxide insufficiency, platelet activation, and arterial thrombosis Circ Res 88 2001 756 762
30. DL Macdonald, TL Terry, and LB Agellon Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1583 1588
31. G Marsche, A Hammer, and O Oskolkova Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport J Biol Chem 277 2002 32172 32179
32. G Marsche, R Heller, and G Fauler 2-Chlorohexadecanal derived from hypochlorite-modified high-density lipoprotein-associated plasmalogen is a natural inhibitor of endothelial nitric oxide biosynthesis Arterioscler Thromb Vasc Biol 24 2004 2302 2306
33. A Miyazaki, S Sakuma, and W Morikawa Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits Arterioscler Thromb Vasc Biol 15 1995 1882 1888
34. M Navab, SY Hama, and GM Anantharamaiah Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 J Lipid Res 41 2000 1481 1494
35. M Navab, JA Berliner, and G Subbanagounder HDL and the inflammatory response induced by LDL-derived oxidized phospholipids Arterioscler Thromb Vasc Biol 21 2001 481 488
36. M Navab, BJ Van Lenten, and ST Reddy High-density lipoprotein and the dynamics of atherosclerotic lesions Circulation 104 2001 2386 2387
37. M Navab, SY Hama, and GP Hough A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J Lipid Res 42 2001 1308 1317
38. SE Nissen, T Tsunoda, and EM Tuzcu Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300
39. J-R Nofer, B Kehrel, and M Fobker HDL and atherosclerosis: beyond reverse cholesterol transport Atherosclerosis 161 2002 1 6
40. U Panzenboeck, S Raitmayer, and H Reicher Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins J Biol Chem 272 1997 29711 29720
41. S Parthasarathy, MT Quinn, and DC Schwenke Oxidative modification of beta-very low density lipoprotein: potential role in monocyte recruitment and foam cell formation Arteriosclerosis 9 1989 398 404
42. S Pennathur, C Bergt, and B Shao Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species J Biol Chem 279 2004 42977 42983
43. AS Plump, CJ Scott, and JL Breslow Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse Proc Natl Acad Sci USA 91 1994 9607 9611
44. EA Podrez, D Schmitt, and HF Hoff Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro J Clin Invest 103 1999 1547 1560
45. EA Podrez, M Febbraio, and N Sheibarni Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species J Clin Invest 105 2000 1095 1108
46. MH Shishehbor, RJ Aviles, and ML Brennan Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy JAMA 289 2003 1675 1680
47. MH Shishehbor, ML Brennan, and RJ Aviles Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 2003 426 431
48. LE Spieker, I Sudano, and D Hurlimann High-density lipoprotein restores endothelial function in hypercholesterolemic men Circulation 105 2002 1399 1402
49. M Syvanne, G Castro, and C Dengremont Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein Atherosclerosis 127 1996 245 253
50. AK Thukkani, J McHowat, and FF Hsu Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133
51. BJ Van Lenten, SY Hama, and FC de Beer Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 96 1995 2758 2767
52. BJ Van Lenten, AC Wagner, and DP Nayak High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection Circulation 103 2001 2283 2288
53. JA Vita, ML Brennan, and N Gokce Serum myeloperoxidase levels independently predict endothelial dysfunction in humans Circulation 110 2004 1134 1139
54. WQ Wang, DL Merriam, and AS Moses Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers J Biol Chem 273 1998 17391 17398
55. R Zhang, ML Brennan, and X Fu Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
56. R Zhang, ML Brennan, and Z Shen Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation J Biol Chem 277 2002 46116 46122
57. L Zheng, B Nukuna, and ML Brennan Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J Clin Invest 114 2004 529 541
58. L Zheng, M Settle, and G Brubaker Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages J Biol Chem 280 2005 38 47